Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation
Brennan J. Wadsworth, Rachel A. Cederberg, Che-Min Lee, Natalie Firmino, S. Elizabeth Franks, Jinhe Pan, Nadine Colpo, Kuo‐Shyan Lin, François Bénard, Kevin L. Bennewith
Topics & Concepts
TelmisartanHypoxia (environmental)LosartanPerfusionAngiotensin IICancer researchMedicinePharmacologyChemistryInternal medicinePathologyReceptorOxygenBlood pressureOrganic chemistryCancer, Hypoxia, and MetabolismCancer, Stress, Anesthesia, and Immune ResponseNanoplatforms for cancer theranostics